Concepedia

Publication | Open Access

Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer

DOIFull Paper Access

53

Citations

28

References

2020

Year

Glenn J. Hanna, Jeffrey P. Guenette, Nicole G. Chau, Cyrus Sayehli, Christian Wilhelm, Robert Metcalf, Deborah Jean Lee Wong, Marcia S. Brose, Mohammad Razaq, Elísabeth Pérez-Ruiz,
Cancer

Abstract

Tipifarnib resulted in modest clinical activity with a promising disease control rate among patients with HRAS-mutant, R/M SGC who developed disease progression within the last 6 months.

References

YearCitations

Page 1